[Lung cancer screening].
Options
BORIS DOI
Publisher DOI
PubMed ID
30542924
Description
CLINICAL/METHODICAL ISSUE
The National Lung Screening Trial (NLST) in 2011 was able to prove for the first time that screening with a low-dose CT can reduce lung carcinoma mortality by 20%. Despite the positive outcome of the NLST, there is-unlike in the USA-currently no systematic lung cancer screening in Europe. This is partly because several significantly smaller screening studies in Europe failed to show any improvement in lung cancer mortality.
STANDARD RADIOLOGICAL METHODS
On the other hand, Europe's healthcare systems differ substantially from those in the United States, so that a direct transfer of US experience to Europe is not possible. For this reason, guidelines for lung cancer screening must be developed in the individual European countries to ensure that lung cancer mortality can be reduced by means of a quality-assured and cost-effective lung cancer screening.
PRACTICAL RECOMMENDATIONS
The experience and the expected results of the European screening studies can provide valuable help for these purposes.
The National Lung Screening Trial (NLST) in 2011 was able to prove for the first time that screening with a low-dose CT can reduce lung carcinoma mortality by 20%. Despite the positive outcome of the NLST, there is-unlike in the USA-currently no systematic lung cancer screening in Europe. This is partly because several significantly smaller screening studies in Europe failed to show any improvement in lung cancer mortality.
STANDARD RADIOLOGICAL METHODS
On the other hand, Europe's healthcare systems differ substantially from those in the United States, so that a direct transfer of US experience to Europe is not possible. For this reason, guidelines for lung cancer screening must be developed in the individual European countries to ensure that lung cancer mortality can be reduced by means of a quality-assured and cost-effective lung cancer screening.
PRACTICAL RECOMMENDATIONS
The experience and the expected results of the European screening studies can provide valuable help for these purposes.
Date of Publication
2019-01
Publication Type
Article
Subject(s)
Keyword(s)
Cost efficacy Health care systems Pulmonary nodules Risk models Study data
Language(s)
de
Series
Der Radiologe
Publisher
Springer
ISSN
1432-2102
Access(Rights)
open.access